Haemodialysis-associated amyloidosis: Difference between revisions
Jump to navigation
Jump to search
m Robot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +) |
m Robot: Automated text replacement (-{{WikiDoc Cardiology Network Infobox}} +, -<references /> +{{reflist|2}}, -{{reflist}} +{{reflist|2}}) |
||
| Line 26: | Line 26: | ||
==References== | ==References== | ||
{{reflist}} | {{reflist|2}} | ||
{{Amyloidosis}} | {{Amyloidosis}} | ||
Latest revision as of 18:08, 4 September 2012
| Haemodialysis-associated amyloidosis | |
| ICD-10 | E85.3 |
|---|---|
| ICD-9 | 277.3 |
| eMedicine | med/3384 |
Haemodialysis-associated amyloidosis is a form of amyloidosis associated with chronic renal failure.[1]
Presentation
Long term haemodialysis results in a gradual accumulation of β2 microglobulin, a serum protein, in the blood. It accumulates because it is unable to cross the dialysis filter.
Prevention
Low copper dialysis is theorized to prevent or delay onset.[2]
References
- ↑ Miyata T, Oda O, Inagi R; et al. (1993). "beta 2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis". J. Clin. Invest. 92 (3): 1243–52. doi:10.1172/JCI116696. PMC 288264. PMID 8376584. Unknown parameter
|month=ignored (help) - ↑ "BU". Text " Amyloid Treatment & Research Program " ignored (help); Text " Doctors " ignored (help); Text " Aß2M Amyloidosis " ignored (help); Text " Clinical Features " ignored (help)
|
Amyloidosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Haemodialysis-associated amyloidosis On the Web |
|
American Roentgen Ray Society Images of Haemodialysis-associated amyloidosis |
|
Risk calculators and risk factors for Haemodialysis-associated amyloidosis |